Teva Pharmaceutical Industries Ltd (TEVJF) Other financing activities (2009 - 2026)

Teva Pharmaceutical Industries (TEVJF) has 18 years of Other financing activities data on file, last reported at -$1.0 million in Q2 2026.

• Quarterly Other financing activities fell 200.0% year-over-year to -$1.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $73.0 million (up 386.67% YoY) and the FY2025 annual result came in at $41.0 million, up 612.5% from the prior year.
• Other financing activities eased to -$1.0 million in Q2 2026, from $36.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $40.0 million in Q4 2025 to a low of -$76.0 million in Q3 2023.
• A 5-year average of -$15.4 million and a median of -$3.0 million in 2022 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities slumped 4100.0% — and 2026, when it soared 1100.0%.
• Tracing TEVJF's Other financing activities over 5 years: stood at -$3.0 million in 2022, then tumbled by 2433.33% to -$76.0 million in 2023, then surged by 114.47% to $11.0 million in 2024, then soared by 263.64% to $40.0 million in 2025, then tumbled by 102.5% to -$1.0 million in 2026.
• The last three Other financing activities figures came in at -$1.0 million (Q2 2026), $36.0 million (Q1 2026), and $40.0 million (Q4 2025), per Business Quant data.